
    
      This is an observational, non-interventional registry designed to assess medication usage
      patterns and to explore, in clinical routine practice, long-term outcomes and relevant
      factors for patient adherence to treatment, in patients receiving antipsychotic treatment
      with risperidone long-acting injectable (RLAI) or oral antipsychotics. Six month
      retrospective data and 1 year prospective data will be collected. According to label
    
  